Accepted for/Published in: JMIR Medical Informatics
Date Submitted: Apr 1, 2021
Date Accepted: Feb 13, 2022
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
A Traditional Chinese Medicine Syndrome Classification Model based on Cross-FGCNN: Model Development and Validation
ABSTRACT
Syndrome differentiation and treatment is the core of traditional Chinese medicine(TCM) in the treatment of diseases. TCM doctors can dialectically classify the syndrome according to the patients' symptoms and conduct treatment. Syndrome differentiation can be regarded as a mathematical model for multi-classification of different high-dimensional sparse symptom vectors. The FGCNN can quickly and effectively extract the nonlinear cross features of sparse vectors in the CTR task. On this basis, we selected the data of 5273 real cases of dysmenorrhea and divided the symptoms into field according to the four diagnosis of TCM, so as to construct an improved Cross-FGCNN model and apply it to the intelligent dialectics of TCM. We used 6 kinds of intelligent dialectical models and 3 kinds of CTR models as comparisons at the same time. Cross-FGCNN can achieve 96.21% accuracy and 0.836 Log-Loss, which is better than other models. We maintain that the model of Cross-FGCNN can automatically extract the linear and nonlinear features of symptoms and classify them, having great potential in the intelligent dialectics of TCM in the future.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.